stella
beta
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease — Stella
Recruiting
Back to PARKINSON DISEASE (Disorder) trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Trial locations
(3 sites)
Germany
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR, Dresden
Centre for Neurology, Department forNeurodegenerative Disease, and Hertie-Institute forClinical Brain Research, Tübingen
Parkinson-Klinik Ortenau GmbH & Co. KG, Wolfach
View full record on ClinicalTrials.gov